# Amylyx Pharmaceuticals, Inc. (AMLX)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/AMLX/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -84.71M | $ -68.34M | $ 5.26M | $ 239.17M |
| 2025 | $ 0 | $ -148.20M | $ -126.43M | $ 5.96M | $ 305.26M |
| 2024 | $ 91.83M | $ -317.16M | $ -176.38M | $ 1.98M | $ 164.77M |
| 2023 | $ 411.73M | $ 53.27M | $ 11.55M | $ 4.24M | $ 433.43M |
| 2022 | $ 24.83M | $ -221.61M | $ -203.76M | $ 6.28M | $ 340.61M |
| 2021 | $ 0 | $ -104.52M | $ -89.33M | $ 0 | $ -151.17M |
| 2020 | $ 0 | $ -10.95M | $ -11.52M | N/A | N/A |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.02 |
| Liabilities / Eq | 0.11 |
| Current Ratio | 12.12 |

## Other views

- [Metrics](https://sponda.capital/en/AMLX.md)
- [Charts](https://sponda.capital/en/AMLX/charts.md)
- [Compare](https://sponda.capital/en/AMLX/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.